India to United States: Itraconazole Export Trade Route

The India to United States Itraconazole corridor is one of India's established pharmaceutical export routes, with 125 shipments documented worth a combined $6.3M USD. The route is dominated by ANNORA PHARMA PRIVATE LIMITED, which alone accounts for roughly 35% of all export value, reflecting the consolidated nature of India's itraconazole manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $50.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with itraconazole's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 25.7%, placing it at rank #10 among India's top itraconazole export destinations globally.

On the import side, key buyers of Indian itraconazole in United States include AMNEAL PHARMACEUTICALS, LLC (KY), ASCEND LABORATORIES,LLC, TO THE ORDER OF.... and 29 others. AMNEAL PHARMACEUTICALS, LLC (KY) is the single largest importer with 12 shipments valued at $957.8K USD.

India's itraconazole exports to United States are driven primarily by a handful of large-scale manufacturers. ANNORA PHARMA PRIVATE LIMITED with 14 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ANNORA PHARMA PRIVATE LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, ALKEM LABORATORIES LIMITED — together account for 80% of total trade value on this route. The average shipment value of $50.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as itraconazole capsules usp,100 mg ndc 65162-0630-03 fda product code 61 w c e 46anda # 205080 unit pack 30 and itraconazole 10mg/ml solution, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AMNEAL PHARMACEUTICALS, LLC (KY) is the largest importer with 12 shipments worth $957.8K USD — representing 15% of all itraconazole imports from India on this route. A total of 32 buyers are active on this corridor.